UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An International Interpretation Study Using the ALK IHC Antibody D5F3 and a Sensitive Detection Kit Demonstrates High Concordance between ALK IHC and ALK FISH and between Evaluators

Journal of thoracic oncology, 2014-05, Vol.9 (5), p.631-638

2014

Volltextzugriff (PDF)

The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation–Positive Non–Small Cell Lung Cancer: Status in 2016

Journal of thoracic oncology, 2016-07, Vol.11 (7), p.946-963

2016

Volltextzugriff (PDF)

Correlation between MET Gene Copy Number by Silver In Situ Hybridization and Protein Expression by Immunohistochemistry in Non-small Cell Lung Cancer

Journal of thoracic oncology, 2012-02, Vol.7 (2), p.340-347

2012

Volltextzugriff (PDF)

The mTOR Pathway in Lung Cancer and Implications for Therapy and Biomarker Analysis

Journal of thoracic oncology, 2012-06, Vol.7 (6), p.947-953

2012

Volltextzugriff (PDF)

The tissue is the issue: personalized medicine for non-small cell lung cancer

Clinical cancer research, 2010-10, Vol.16 (20), p.4909-4911

2010

Volltextzugriff (PDF)

Increased ALK Gene Copy Number and Amplification are Frequent in Non-small Cell Lung Cancer

Journal of thoracic oncology, 2011-01, Vol.6 (1), p.21-27

2011

Volltextzugriff (PDF)

Novel Epidermal Growth Factor Receptor Mutation-Specific Antibodies for Non-small Cell Lung Cancer: Immunohistochemistry as a Possible Screening Method for Epidermal Growth Factor Receptor Mutations

Journal of thoracic oncology, 2010-10, Vol.5 (10), p.1551-1558

2010

Volltextzugriff (PDF)

Natural History and Real-World Treatment Outcomes for Patients With NSCLC Having EGFR Exon 20 Insertion Mutation: An International Association for the Study of Lung Cancer–American Society of Clinical Oncology CancerLinQ Study

JTO clinical and research reports, 2024-06, Vol.5 (6), p.100592-100592, Article 100592

2024

Volltextzugriff (PDF)

PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project

Journal of thoracic oncology, 2018-09, Vol.13 (9), p.1302-1311

2018

Volltextzugriff (PDF)

Contributions of KRAS and RAL in Non–Small-Cell Lung Cancer Growth and Progression

Journal of thoracic oncology, 2013-12, Vol.8 (12), p.1492-1501

2013

Volltextzugriff (PDF)

Increased cell surface Fas expression is necessary and sufficient to sensitize lung fibroblasts to Fas ligation-induced apoptosis: implications for fibroblast accumulation in idiopathic pulmonary fibrosis

The Journal of immunology (1950), 2011-07, Vol.187 (1), p.527-537

2011

Volltextzugriff (PDF)

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

Archives of pathology & laboratory medicine (1976), 2018-03, Vol.142 (3), p.321-346

2018

Volltextzugriff (PDF)

Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC

Journal of thoracic oncology, 2018-09, Vol.13 (9), p.1248-1268

2018

Volltextzugriff (PDF)

EGFR Protein Expression in Non-Small Cell Lung Cancer Predicts Response to an EGFR Tyrosine Kinase Inhibitor―A Novel Antibody for Immunohistochemistry or AQUA Technology

Clinical cancer research, 2011-12, Vol.17 (24), p.7796-7807

2011

Volltextzugriff (PDF)

Independent validation test of the vote-counting strategy used to rank biomarkers from published studies

Biomarkers in medicine, 2015-08, Vol.9 (8), p.751-761

2015

Volltextzugriff (PDF)

The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer

Journal of thoracic oncology, 2020-09, Vol.15 (9), p.1434-1448

2020

Volltextzugriff (PDF)

IL-4-induced macrophage-derived IGF-I protects myofibroblasts from apoptosis following growth factor withdrawal

Journal of leukocyte biology, 2004-11, Vol.76 (5), p.1019-1027

2004

Volltextzugriff (PDF)

Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic

Journal of thoracic oncology, 2020-07, Vol.15 (7), p.1119-1136

2020

Volltextzugriff (PDF)

Early detection and screening of lung cancer

Expert review of molecular diagnostics, 2010-09, Vol.10 (6), p.799-815

2010

Volltextzugriff (PDF)

Thymidylate Synthase Protein Expression by IHC and Gene Copy Number by SISH Correlate and Show Great Variability in Non–Small Cell Lung Cancer

Journal of thoracic oncology, 2012-06, Vol.7 (6), p.982-992

2012

Volltextzugriff (PDF)

FGFR1 mRNA and Protein Expression, not Gene Copy Number, Predict FGFR TKI Sensitivity across All Lung Cancer Histologies

Clinical cancer research, 2014-06, Vol.20 (12), p.3299-3309

2014

Volltextzugriff (PDF)

Next-Generation Sequencing Identifies and Immunohistochemistry Confirms a Novel Crizotinib-Sensitive ALK Rearrangement in a Patient with Metastatic Non–Small-Cell Lung Cancer

Journal of thoracic oncology, 2012-09, Vol.7 (9), p.e14-e16

2012

Volltextzugriff (PDF)

Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung Cancer

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.1373-1414

2024

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(63)
Dissertationen
(1)

Sprache

Englisch
(64)

Erscheinungsjahr

n.n

Thema

Science & Technology
(47)
Life Sciences & Biomedicine
(46)
Humans
(36)
Oncology
(33)
Respiratory System
(32)
Female
(16)
Lung Neoplasms - Genetics
(16)
Male
(15)
Lung Neoplasms - Drug Therapy
(14)
Lung Neoplasms - Pathology
(14)
Middle Aged
(14)
Animals
(12)
Lung Cancer
(12)
Aged
(11)
Carcinoma, Non-Small-Cell Lung - Genetics
(11)
Mice
(10)
Biomarkers
(9)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(9)
Lung Neoplasms - Metabolism
(9)
Neoplasm Staging
(9)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(57)
MEDLINE
(42)
Journals@Ovid
(39)
Publisher website
(20)
IngentaConnect
(10)
Elsevier ScienceDirect Journals Complete
(5)
JSTOR
(2)
SAGE Journals Online
(2)
Taylor & Francis Journals
(2)
Taylor & Francis
(2)
Wiley Online Library
(1)
Oxford Journals
(1)
ProQuest Dissertations & Theses A&I
(1)
IngentaConnect Journals
(1)
Springer Online Journals
(1)

10 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An International Interpretation Study Using the ALK IHC Antibody D5F3 and a Sensitive Detection Kit Demonstrates High Concordance between ALK IHC and ALK FISH and between Evaluators

The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation–Positive Non–Small Cell Lung Cancer: Status in 2016

Correlation between MET Gene Copy Number by Silver In Situ Hybridization and Protein Expression by Immunohistochemistry in Non-small Cell Lung Cancer

The mTOR Pathway in Lung Cancer and Implications for Therapy and Biomarker Analysis

The tissue is the issue: personalized medicine for non-small cell lung cancer

Increased ALK Gene Copy Number and Amplification are Frequent in Non-small Cell Lung Cancer

Novel Epidermal Growth Factor Receptor Mutation-Specific Antibodies for Non-small Cell Lung Cancer: Immunohistochemistry as a Possible Screening Method for Epidermal Growth Factor Receptor Mutations

Natural History and Real-World Treatment Outcomes for Patients With NSCLC Having EGFR Exon 20 Insertion Mutation: An International Association for the Study of Lung Cancer–American Society of Clinical Oncology CancerLinQ Study

PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project

Contributions of KRAS and RAL in Non–Small-Cell Lung Cancer Growth and Progression

Increased cell surface Fas expression is necessary and sufficient to sensitize lung fibroblasts to Fas ligation-induced apoptosis: implications for fibroblast accumulation in idiopathic pulmonary fibrosis

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

EGFR Protein Expression in Non-Small Cell Lung Cancer Predicts Response to an EGFR Tyrosine Kinase Inhibitor―A Novel Antibody for Immunohistochemistry or AQUA Technology

Independent validation test of the vote-counting strategy used to rank biomarkers from published studies

The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer

IL-4-induced macrophage-derived IGF-I protects myofibroblasts from apoptosis following growth factor withdrawal

Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic

Early detection and screening of lung cancer

Thymidylate Synthase Protein Expression by IHC and Gene Copy Number by SISH Correlate and Show Great Variability in Non–Small Cell Lung Cancer

FGFR1 mRNA and Protein Expression, not Gene Copy Number, Predict FGFR TKI Sensitivity across All Lung Cancer Histologies

Next-Generation Sequencing Identifies and Immunohistochemistry Confirms a Novel Crizotinib-Sensitive ALK Rearrangement in a Patient with Metastatic Non–Small-Cell Lung Cancer

Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung Cancer

Suchergebnisse filtern